Novavax COVID-19 vaccine Nuvaxovid approved by MHRA

Nuvaxovid becomes the fifth COVID-19 vaccine authorised in UK. It is distinct from other COVID-19 vaccines currently in UK as it uses recombinant protein-based technology which has been used for many years in development of vaccines to prevent other illnesses.